Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange Detected- Page revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded notes that publications are provided voluntarily by the study submitter and that some publication data are automatically pulled from PubMed, along with a system revision tag ('Revision: v3.3.1'). The previous wording stating that publications are automatically created by ClinicalTrials.gov from PubMed data, potentially about the study, was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check29 days agoChange DetectedThe government funding/operating status notification on the page has been removed. This change does not affect the study details, eligibility criteria, or contact information.SummaryDifference0.2%

- Check43 days agoChange DetectedNo significant content changes detected on the Study Details page. The sections including eligibility criteria, interventions, outcomes, and locations appear unchanged from the prior version.SummaryDifference0.3%

- Check71 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.